SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Sanaria Inc. Receives Multi-Year U.S. NIH Phase II Small Business Innovation Research Grant to Develop a Genetically Attenuated Whole Parasite Malaria Vaccine